Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1-integrin-dependent mechanism

International Journal of Cancer

Volumn 138, Issue 4, 2016, Pages 964-975

  Widder, Miriam ^a   Lützkendorf, Jana ^a   Caysa, Henrike ^b   Unverzagt, Susanne ^b   Wickenhauser, Claudia ^b   Benndorf, Ralf A ^b,c   Schmoll, Hans Joachim ^a   Müller Tidow, Carsten ^a   Müller, Thomas ^a   Müller, Lutz P ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Inst fur Bioprozeß und A   (Germany)

Author keywords

CRC; growth promotion; MSC; tumor stroma interactions; 1 integrin

Indexed keywords

ALPHA CATENIN; BETA1 INTEGRIN; COLLAGEN TYPE 1; SCLEROPROTEIN; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER CELL LINE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STROMA CELL; MITOSIS; MULTIPOTENT STEM CELL; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR SEEDING; TUMOR SPHEROID; TUMOR XENOGRAFT; ANIMAL; COCULTURE; COLORECTAL TUMOR; GENE SILENCING; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; ANTIGENS, CD29; BLOTTING, WESTERN; CELL LINE, TUMOR; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

EID: 84954367162     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29844     Document Type: Article

References (41)

1. Ferlay J, Soerjomataram I, Dikshit R, et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86.
2. Fearon ER., Molecular genetics of colorectal cancer. Annu Rev Pathol 2011; 6: 479-507.
3. Tsanou E, Peschos D, Batistatou A, et al., The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res 2008; 28: 3815-26.
4. Brabletz T, Jung A, Spaderna S, et al., Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5: 744-9.
5. Bacman D, Merkel S, Croner R, et al., TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer 2007; 7: 156.
6. Spaeth E, Klopp A, Dembinski J, et al., Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008; 15: 730-8.
7. Rønnov-Jessen L, Petersen OW, Bissell MJ., Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996; 76: 69-125.
8. Tlsty TD, Hein PW., Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001; 11: 54-9.
9. Lazennec G, Jorgensen C., Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 2008; 26: 1387-94.
10. Crisan M, Yap S, Casteilla L, et al., A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-13.
11. Khakoo AY, Pati S, Anderson SA, et al., Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006; 203: 1235-47.
12. Hung S, Deng W, Yang WK, et al., Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005; 11: 7749-56.
13. Direkze NC, Hodivala-Dilke K, Jeffery R, et al., Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004; 64: 8492-5.
14. Mishra PJ, Mishra PJ, Humeniuk R, et al., Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008; 68: 4331-9.
15. Jeon ES, Moon HJ, Lee MJ, et al., Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells 2008; 26: 789-97.
16. Karnoub AE, Dash AB, Vo AP, et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-63.
17. Mele V, Muraro MG, Calabrese D, et al., Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β. Int J Cancer 2014; 134: 2583-94.
18. Luetzkendorf J, Mueller LP, Mueller T, et al., Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. J Cell Mol Med 2010; 14: 2292-304.
19. Mueller LP, Luetzkendorf J, Mueller T, et al., Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction. Stem Cells 2006; 24: 2753-65.
20. Caysa H, Hoffmann S, Luetzkendorf J, et al., Monitoring of xenograft tumor growth and response to chemotherapy by non-invasive in vivo multispectral fluorescence imaging. PLoS One 2012; 7: e47927.
21. Yuhas JM, Li AP, Martinez AO, et al., A simplified method for production and growth of multicellular tumor spheroids. Cancer Res 1977; 37: 3639-43.
22. Mueller T, Voigt W, Simon H, et al., Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res 2003; 63: 513-21.
23. Mueller T, Luetzkendorf J, Nerger K, et al., Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell Mol Life Sci 2009; 66: 495-503.
24. Kunz-Schughart LA., Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int 1999; 23: 157-61.
25. Bae S, Ahn JH, Park CW, et al., Gene and microRNA expression signatures of human mesenchymal stromal cells in comparison to fibroblasts. Cell Tissue Res 2009; 335: 565-73.
26. da Silva Meirelles L, Caplan AI, Nardi NB., In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008; 26: 2287-99.
27. Quail DF, Joyce JA., Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19: 1423-37.
28. Ivascu A, Kubbies M., Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 2007; 31: 1403-13.
29. Xiong J, Balcioglu HE, Danen EHJ., Integrin signaling in control of tumor growth and progression. Int J Biochem Cell Biol 2013; 45: 1012-15.
30. Howe GA, Addison CL., β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy. Cell Adh Migr 2012; 6: 71-7.
31. Kirkland SC, Ying H., Alpha2beta1 integrin regulates lineage commitment in multipotent human colorectal cancer cells. J Biol Chem 2008; 283: 27612-19.
32. Oosterling SJ, van der Bij Gerben J, Bögels M, et al., Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces. Ann Surg 2008; 247: 85-94.
33. Park CW, Kim K, Bae S, et al., Cytokine secretion profiling of human mesenchymal stem cells by antibody array. Int J Stem Cells 2009; 2: 59-68.
34. Silva WA, Covas DT, Panepucci RA, et al., The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003; 21: 661-9.
35. Popov C, Radic T, Haasters F, et al., Integrins α2β1 and α11β1 regulate the survival of mesenchymal stem cells on collagen I. Cell Death Dis 2011; 2: e186.
36. Pickup MW, Mouw JK, Weaver VM., The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 2014; 15: 1243-53.
37. Kirkland SC., Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br J Cancer 2009; 101: 320-6.
38. Zou X, Feng B, Dong T, et al., Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis. J Proteomics 2013; 94: 473-85.
39. Oku Y, Shimoji T, Takifuji K, et al., Identification of the molecular mechanisms for dedifferentiation at the invasion front of colorectal cancer by a gene expression analysis. Clin Cancer Res 2008; 14: 7215-22.
40. Song J, Zhang J, Wang J, et al., β1 Integrin modulates tumor growth and apoptosis of human colorectal cancer. Oncol Rep 2014; 32: 302-8.
41. Kren A, Baeriswyl V, Lehembre F, et al., Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J 2007; 26: 2832-42.